206 related articles for article (PubMed ID: 29379088)
1. The inflammatory effects of TNF-α and complement component 3 on coagulation.
Page MJ; Bester J; Pretorius E
Sci Rep; 2018 Jan; 8(1):1812. PubMed ID: 29379088
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8.
Bester J; Matshailwe C; Pretorius E
Cytokine; 2018 Oct; 110():237-242. PubMed ID: 29396046
[TBL] [Abstract][Full Text] [Related]
3. Human complement C3 is a substrate for transglutaminases. A functional link between non-protease-based members of the coagulation and complement cascades.
Nikolajsen CL; Scavenius C; Enghild JJ
Biochemistry; 2012 Jun; 51(23):4735-42. PubMed ID: 22630814
[TBL] [Abstract][Full Text] [Related]
4. Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.
Swanepoel AC; Nielsen VG; Pretorius E
Inflammation; 2015 Aug; 38(4):1707-26. PubMed ID: 25772112
[TBL] [Abstract][Full Text] [Related]
5. Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography study.
van Rooy MJ; Duim W; Ehlers R; Buys AV; Pretorius E
Cardiovasc Diabetol; 2015 Jul; 14():86. PubMed ID: 26140921
[TBL] [Abstract][Full Text] [Related]
6. Platelets derived from fresh and cold-stored whole blood participate in clot formation in rats with acute traumatic coagulopathy.
Wu X; Darlington DN; Montgomery RK; Liu B; Keesee JD; Scherer MR; Benov A; Chen J; Cap AP
Br J Haematol; 2017 Dec; 179(5):802-810. PubMed ID: 29168170
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of coagulation kinetics using thromboelastometry-methodologic influence of activator and test medium.
Sørensen B; Fenger-Eriksen C; Christiansen K; Larsen OH; Ingerslev J
Ann Hematol; 2010 Nov; 89(11):1155-61. PubMed ID: 20480163
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of platelet function in trauma patients.
Ramsey MT; Fabian TC; Shahan CP; Sharpe JP; Mabry SE; Weinberg JA; Croce MA; Jennings LK
J Trauma Acute Care Surg; 2016 May; 80(5):726-32; discussion 732-3. PubMed ID: 26895088
[TBL] [Abstract][Full Text] [Related]
9. Hemocompatibility studies on a degradable polar hydrophobic ionic polyurethane (D-PHI).
Brockman KS; Kizhakkedathu JN; Santerre JP
Acta Biomater; 2017 Jan; 48():368-377. PubMed ID: 27818307
[TBL] [Abstract][Full Text] [Related]
10. A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time.
Six KR; Devloo R; Van Aelst B; Vandekerckhove P; Feys HB; Compernolle V
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287584
[TBL] [Abstract][Full Text] [Related]
11. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
Ekdahl KN; Nilsson B
J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
[TBL] [Abstract][Full Text] [Related]
12. The influence of inflammation and hematocrit on clot strength in canine thromboelastographic hypercoagulability.
Marschner CB; Wiinberg B; Tarnow I; Markussen B; Kühnel L; Bochsen L; Kristensen AT
J Vet Emerg Crit Care (San Antonio); 2018 Jan; 28(1):20-30. PubMed ID: 29171709
[TBL] [Abstract][Full Text] [Related]
13. Thrombin induced platelet-fibrin clot strength measured by thrombelastography is a novel marker of platelet activation in acute myocardial infarction.
Wu H; Qian J; Wang Q; Lv H; Sun A; Ge J
Int J Cardiol; 2014 Mar; 172(1):e24-5. PubMed ID: 24433621
[No Abstract] [Full Text] [Related]
14. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
Rataj D; Werwitzke S; Haarmeijer B; Winkler M; Ramackers W; Petersen B; Niemann H; Wünsch A; Bähr A; Klymiuk N; Wolf E; Abicht JM; Ayares D; Tiede A
Xenotransplantation; 2016 Mar; 23(2):117-27. PubMed ID: 26773447
[TBL] [Abstract][Full Text] [Related]
15. Abnormal blood clot formation induced by temperature responsive polymers by altered fibrin polymerization and platelet binding.
Lai BF; Zou Y; Yang X; Yu X; Kizhakkedathu JN
Biomaterials; 2014 Mar; 35(8):2518-28. PubMed ID: 24388385
[TBL] [Abstract][Full Text] [Related]
16. Platelet activity is negatively modulated by tumor necrosis factor alpha through reductions of cytosolic calcium levels and integrin alphaIIbbeta3 phosphorylation.
Bonfitto PHL; Naime ACA; Lopes-Pires ME; Goulart G; Mendes-Silverio CB; Bueno PI; Castilho RF; Antunes E; Marcondes S
Thromb Res; 2018 Dec; 172():44-50. PubMed ID: 30359790
[TBL] [Abstract][Full Text] [Related]
17. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
18. Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18.
Hamad OA; Mitroulis I; Fromell K; Kozarcanin H; Chavakis T; Ricklin D; Lambris JD; Ekdahl KN; Nilsson B
Thromb Haemost; 2015 Nov; 114(6):1207-17. PubMed ID: 26293614
[TBL] [Abstract][Full Text] [Related]
19. Association between standard laboratory and functional tests of coagulation in dilutional coagulopathy: an in vitro study.
Krzych LJ; Czempik PF
J Physiol Pharmacol; 2017 Aug; 68(4):637-645. PubMed ID: 29151081
[TBL] [Abstract][Full Text] [Related]
20. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry.
Boldt J; Wolf M; Mengistu A
Anesth Analg; 2007 Feb; 104(2):425-30. PubMed ID: 17242103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
